A decade of melanomas: Identification of factors associated with delayed detection in an academic group practice

Dermatologic Surgery

Volumn 37, Issue 11, 2011, Pages 1620-1630

  Goodson, Agnessa Gadeliya ^a   Florell, Scott R ^a   Boucher, Kenneth M ^a,b   Grossman, Douglas ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CLINICAL FEATURE; DIAGNOSTIC DELAY; DYSPLASTIC NEVUS; FEMALE; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MELANOMA; MOTIVATION; PATIENT DECISION MAKING; PHYSICIAN; PREDICTIVE VALUE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SKIN BIOPSY;

DELAYED DIAGNOSIS; GROUP PRACTICE; HEAD AND NECK NEOPLASMS; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; INCIDENCE; MELANOMA; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; UTAH;

EID: 80755146056     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.02097.x     Document Type: Article

References (32)

1. Murray CS, Stockton DL, Doherty VR., Thick melanoma: the challenge persists. Br J Dermatol 2005; 152: 104-9.
2. Linos E, Swetter SM, Cockburn MG, Colditz GA, et al,. Increasing burden of melanoma in the United States. J Invest Dermatol 2009; 129: 1666-74.
3. Criscione VD, Weinstock MA., Melanoma thickness trends in the United States, 1988-2006. J Invest Dermatol 2010; 130: 793-7.
4. Hodi FS, O'Day SJ, McDermott DF, Weber RW, et al,. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711-23.
5. Flaherty KT, Puzanov I, Kim KB, Ribas A, et al,. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010; 363: 809-19.
6. Cho YR, Chiang MP., Epidemiology, staging (new system), and prognosis of cutaneous melanoma. Clin Plast Surg 2010; 37: 47-53.
7. Fuller SR, Bowen GM, Tanner B, Florell SR, et al,. Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma. Dermatol Surg 2007; 33: 1198-206.
8. Goodson AG, Florell SR, Hyde M, Bowen GM, et al,. Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatol Surg 2010; 36: 1087-98.
9. Psaty EL, Scope A, Halpern AC, Marghoob AA., Defining the patient at high risk for melanoma. Int J Dermatol 2010; 49: 362-76.
10. Smalberger GJ, Siegel DM, Khachemoune A., Lentigo maligna. Dermatol Ther 2008; 21: 439-46.
11. Andtbacka RH, Gershenwald JE., Role of sentinel lymph node biopsy in patients with thin melanoma. J Natl Compr Canc Netw 2009; 7: 308-17.
12. Goodson AG, Grossman D., Strategies for early melanoma detection: approaches to the patient with nevi. J Am Acad Dermatol 2009; 60: 719-35.
13. Wender RC., Barriers to effective skin cancer detection. Cancer 1995; 75: 691-8.
14. Tripp JM, Kopf AW, Marghoob AA, Bart RS., Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology. J Am Acad Dermatol 2002; 46: 674-82.
15. Carmichael VE, Wilson KS., Primary cutaneous malignant melanoma: experience of the British Columbia Cancer Agency from 1972 to 1981. Can J Surg 1992; 35: 589-97. (Pubitemid 23037602)
16. Jelfs PL, Giles G, Shugg D, Coates M, et al,. Cutaneous malignant melanoma in Australia, 1989. Med J Aust 1994; 161: 182-7. (Pubitemid 2125722)
17. Jones WO, Harman CR, Ng AK, Shaw JH., Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world. World J Surg 1999; 23: 732-5. (Pubitemid 29314419)
18. Swetter SM, Boldrick JC, Jung SY, Egbert BM, et al,. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol 2005; 125: 685-91.
19. Forman SB, Ferringer TC, Peckham SJ, Dalton SR, et al,. Is superficial spreading melanoma still the most common form of malignant melanoma? J Am Acad Dermatol 2008; 58: 1013-20. (Pubitemid 351657607)
20. Marks R, Dorevitch AP, Mason G., Do all melanomas come from "moles"? A study of the histological association between melanocytic naevi and melanoma. Australas J Dermatol 1990; 31: 77-80.
21. Bevona C, Goggins W, Quinn T, Fullerton J, et al,. Cutaneous melanomas associated with nevi. Arch Dermatol 2003; 139: 1620-4. (Pubitemid 37523082)
22. Weatherhead SC, Haniffa M, Lawrence CM., Melanomas arising from naevi and de novo melanomas-does origin matter? Br J Dermatol 2007; 156: 72-6. (Pubitemid 44924147)
23. Tong AK, Murphy GF, Mihm MC Jr., Dysplastic nevus: a formal histogenetic precursor of malignant melanoma. Monogr Pathol 1988; 10-8.
24. Sober AJ, Burstein JM., Precursors to skin cancer. Cancer 1995; 75: 645-50.
25. Roesch A, Burgdorf W, Stolz W, Landthaler M, et al,. Dermatoscopy of "dysplastic nevi": a beacon in diagnostic darkness. Eur J Dermatol 2006; 16: 479-93. (Pubitemid 44861821)
26. Lucas CR, Sanders LL, Murray JC, Myers SA, et al,. Early melanoma detection: nonuniform dermoscopic features and growth. J Am Acad Dermatol 2003; 48: 663-71. (Pubitemid 36583275)
27. Banky JP, Kelly JW, English DR, Yeatman JM, et al,. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol 2005; 141: 998-1006. (Pubitemid 46165523)
28. Richard MA, Grob JJ, Avril MF, Delaunay M, et al,. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer 2000; 89: 271-9. (Pubitemid 30430744)
29. Roetzheim RG, Pal N, van Durme DJ, Wathington D, et al,. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol 2000; 43: 211-8. (Pubitemid 30625995)
30. Swetter SM, Soon S, Harrington CR, Chen SC., Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study. Arch Dermatol 2007; 143: 30-6. (Pubitemid 46143193)
31. Schmid-Wendtner MH, Baumert J, Stange J, Volkenandt M., Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients. Melanoma Res 2002; 12: 389-94. (Pubitemid 34816445)
32. Walter FM, Humphrys E, Tso S, Johnson M, et al,. Patient understanding of moles and skin cancer, and factors influencing presentation in primary care: a qualitative study. BMC Fam Pract 11: 62-71.